Source: Nauck MA, Meier JJ, "Are All GLP-1 Agonists Equal in the Treatment of Type 2 Diabetes?", European Journal of Endocrinology, 2019
A 10 mg/mL semaglutide vial and a 10 mg/mL tirzepatide vial both deliver exactly 5.0 mg at 50 units
4 Evidence from recent research A recent meta-analysis of 11 randomised controlled trials, including 840 participants, examined the effects of GLP-1s on reproductive and metabolic outcomes in women with PCOS
Notably, 77% of Vital Pursuit sales come from households without current GLP-1 users, suggesting health-conscious consumers broadly are adopting these products. Conagra introduced On Track badges on 26 Healthy Choice frozen meals in early 2025, flagging products as high-protein, low-calorie, and fiber-rich
N., & Hansen, K
In obese mouse models, combining retatrutide with gemcitabine overcame gemcitabine resistance, resulting in significant reductions in both tumor growth and tumor weight